Cerebral Oximetry Monitoring in Extremely Preterm Infants.
暂无分享,去创建一个
G. Dimitriou | A. Curley | G. Greisen | H. Fuchs | O. Baud | F. Mosca | M. Fumagalli | J. Jakobsen | A. Smits | L. Thewissen | G. Naulaers | A. Truttmann | A. Klamer | C. Hagmann | A. El-Khuffash | G. H. Hahn | G. Pichler | B. Urlesberger | L. Chalak | G. Vento | M. Wilińska | E. Mastretta | M. Baserga | K. Sarafidis | A. Alarcon | E. Ergenekon | M. Stocker | M. Agosti | Z. Vesoulis | M. H. Olsen | M. Çetinkaya | E. Hatzidaki | B. Królak-Olejnik | S. Nesargi | E. Valverde | S. Hyttel-Sorensen | L. Arruza | R. Lauterbach | S. Marciniak | A. Pellicer | J. Mintzer | M. Hansen | M. I. Rasmussen | G. Cheng | Xin Xu | M. Ybarra | Tone Nordvik | S. Fredly | A. Memişoğlu | N. Koksal | A. Hopper | S. Pisoni | J. Miletin | P. Agergaard | Zhaoqing Yin | C. Gluud | T. Szczapa | I. Sadowska-Krawczenko | B. Rzepecka-Węglarz | E. Bergón-Sendín | C. Morales-Betancourt | I. de las Cuevas | M. Bas | A. Heuchan | J. Tkaczyk | H. Ozkan | L. Cornette | J. Baumgartner | Ling Yang | C. Lecart | L. Bender | E. Papathoma | P. Korček | Claudia Knöpfli | E. Dempsey | J. Širc | I. Serrano-Viñuales | S. Zeng | Salvador Piris-Borregas | P. Maton | J. Kučera | E. Skylogianni | A. Bargiel | Ş. Oğuz | K. Tsoni | B. Yaşa | Marta Teresa-Palacio | Pamela Zafra | Ruth del Rio Florentino | T. Karen | Xiao-Min Gao | M. Kadri | Elżbieta Rafińska-Ważny | Zhang Peng | J. de Buyst | D. Healy | S. G. Kersin | O. O. Vaccarello | B. L. González | L. S. Lopez | M. Akin | Anja Hergenhan | Miguel Alsina-Casanova | Karen McCall | Lin Huijia | Shashidhar A Rao | Catalina Morales-Betancourt | Veronika Karadyova | Le Wang | Rebeca Sánchez-Salmador | Aksel K Jensen | S. Kersin | Eleni Skylogianni | Eugene Dempsey | Iwona Sadowska-Krawczenko | Itziar Serrano-Viñuales | S. A. Rao
[1] G. Greisen,et al. Cerebral near-infrared spectroscopy monitoring (NIRS) in children and adults: a systematic review with meta-analysis , 2022, Pediatric Research.
[2] G. Dimitriou,et al. Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach , 2021, BMC Medical Research Methodology.
[3] P. Shah,et al. Duration of and trends in respiratory support among extremely preterm infants , 2020, Archives of Disease in Childhood.
[4] G. Dimitriou,et al. Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants , 2019, Trials.
[5] G. Dimitriou,et al. Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial , 2019, Trials.
[6] G. Greisen,et al. Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III , 2019, Trials.
[7] P. Smielewski,et al. Changes in hemodynamics, cerebral oxygenation and cerebrovascular reactivity during the early transitional circulation in preterm infants , 2019, Pediatric Research.
[8] K. Lui,et al. Patterns of use of near‐infrared spectroscopy in neonatal intensive care units: international usage survey , 2018, Acta paediatrica.
[9] B. Vohr,et al. Neurodevelopmental Impairment Among Extremely Preterm Infants in the Neonatal Research Network , 2018, Pediatrics.
[10] M. Kluckow. The Pathophysiology of Low Systemic Blood Flow in the Preterm Infant , 2018, Front. Pediatr..
[11] Per Winkel,et al. When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts , 2017, BMC Medical Research Methodology.
[12] Julian P T Higgins,et al. Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study , 2017, American journal of epidemiology.
[13] F. Gilles,et al. Hypoxia–ischemia is not an antecedent of most preterm brain damage: the illusion of validity , 2017, Developmental medicine and child neurology.
[14] N. Modi,et al. Research ethics committee decision-making in relation to an efficient neonatal trial , 2016, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[15] Martin Wolf,et al. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial , 2015, BMJ : British Medical Journal.
[16] E. Dempsey,et al. The SafeBoosC Phase II Randomised Clinical Trial: A Treatment Guideline for Targeted Near-Infrared-Derived Cerebral Tissue Oxygenation versus Standard Treatment in Extremely Preterm Infants , 2013, Neonatology.
[17] B. Poindexter,et al. Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.
[18] Anna L. Ells,et al. The International Classification of Retinopathy of Prematurity revisited. , 2005, Archives of ophthalmology.
[19] G. Greisen. Autoregulation of cerebral blood flow in newborn babies. , 2005, Early human development.
[20] G. Greisen,et al. Cerebral palsy births in eastern Denmark, 1987--90: implications for neonatal care. , 2001, Paediatric and perinatal epidemiology.
[21] G. Greisen,et al. Cerebral Blood Flow, PaCO2 Changes, and Visual Evoked Potentials in Mechanically Ventilated, Preterm Infants , 1987, Acta paediatrica Scandinavica.
[22] G. Greisen,et al. Is periventricular leucomalacia a result of hypoxic-ischaemic injury? Hypocapnia and the preterm brain. , 2001, Biology of the neonate.